BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei X, Song M, Li W, Huang J, Yang G, Wang Y. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance. Theranostics 2021;11:6334-54. [PMID: 33995661 DOI: 10.7150/thno.59342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Jia L, Liu N, Zhao Y, Zhang T, Xie X. Inside-out extracellular vesicles-like biomimetic magnetic nanoparticles for efficient screening P-Glycoprotein inhibitors to overcome cancer multidrug resistance. Colloids Surf B Biointerfaces 2023;222:113134. [PMID: 36630772 DOI: 10.1016/j.colsurfb.2023.113134] [Reference Citation Analysis]
2 Arya JS, Joseph MM, Murali VP, Vidyalekshmi MS, Maiti KK. Targeted Delivery Polymeric Nanosystem Reinforced by Synergism of Embilin and RPI-1 for Therapeutics of Pancreatic Cancer. ACS Appl Nano Mater 2022. [DOI: 10.1021/acsanm.2c04400] [Reference Citation Analysis]
3 Wei X, Wang J, Liang M, Song M. Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy. Theranostics 2022;12:7821-52. [PMID: 36451865 DOI: 10.7150/thno.78572] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Motofei IG. Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Semin Cancer Biol 2022;86:600-15. [PMID: 34695580 DOI: 10.1016/j.semcancer.2021.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kaur J, Raza K, Preet S. Organogel mediated co-delivery of nisin and 5-fluorouracil: a synergistic approach against skin cancer. J Microencapsul 2022;39:609-25. [PMID: 36472891 DOI: 10.1080/02652048.2022.2149871] [Reference Citation Analysis]
6 Yadav P, Ambudkar SV, Rajendra Prasad N. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01626-z] [Reference Citation Analysis]
7 Ouyang F, Zhang X, Zhang L, Liu Y, Shuai Q. Enhanced photo-hypoxia-activated combination therapy traced by AIE photosensitizer and targeted by hyaluronic acid: Disulphide bond interference of detoxification barrier. Journal of Photochemistry and Photobiology B: Biology 2022;234:112535. [DOI: 10.1016/j.jphotobiol.2022.112535] [Reference Citation Analysis]
8 Zhao T, Liang C, Zhao Y, Xue X, Ma Z, Qi J, Shen H, Yang S, Zhang J, Jia Q, Du Q, Cao D, Xiang B, Zhang H, Qi X. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01383-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang C, Zhou X, Zhang H, Han X, Li B, Yang R, Zhou X. Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer. Front Pharmacol 2022;13:776895. [DOI: 10.3389/fphar.2022.776895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Iqbal S, Zhao Z. Poly (β amino esters) copolymers: Novel potential vectors for delivery of genes and related therapeutics. Int J Pharm 2022;611:121289. [PMID: 34775041 DOI: 10.1016/j.ijpharm.2021.121289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Katekar R, Singh P, Garg R, Verma S, Gayen JR. Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers. Pharm Dev Technol 2021;:1-13. [PMID: 34806547 DOI: 10.1080/10837450.2021.2009861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Niu B, Liao K, Zhou Y, Wen T, Quan G, Wu C, Pan X. Cellular defense system-destroying nanoparticles as a platform for enhanced chemotherapy against drug-resistant cancer. Mater Sci Eng C Mater Biol Appl 2021;131:112494. [PMID: 34857280 DOI: 10.1016/j.msec.2021.112494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Liu H, Qiao Z, Jang YO, Kim MG, Zou Q, Lee HJ, Koo B, Kim SH, Yun K, Kim HS, Shin Y. Diatomaceous earth/zinc oxide micro-composite assisted antibiotics in fungal therapy. Nano Converg 2021;8:32. [PMID: 34694514 DOI: 10.1186/s40580-021-00283-6] [Reference Citation Analysis]
14 Lin W, Sun J, Sadahira T, Xu N, Wada K, Liu C, Araki M, Xu A, Watanabe M, Nasu Y, Huang P. Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer. Int J Biol Sci 2021;17:3255-67. [PMID: 34421363 DOI: 10.7150/ijbs.63125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]